| Funding Opportunity ID: |
321453 |
| Opportunity Number: |
N62645-PA-20-01 |
| Opportunity Title: |
Conduct of Clinical Trials to Facilitate the Development and Approval of Novel Countermeasures (vaccines, devices, drugs) for Use by the Warfighter |
| Opportunity Category: |
Discretionary |
| Opportunity Category Explanation: |
|
| Funding Instrument Type: |
Cooperative Agreement |
| Category of Funding Activity: |
Science and Technology and other Research and Development |
| Category Explanation: |
|
| CFDA Number(s): |
12.340 |
| Eligible Applicants: |
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: |
|
| Agency Code: |
DOD-ONR-MED |
| Agency Name: |
Department of Defense
NAVAL MEDICAL LOGISTICS COMMAND |
| Posted Date: |
Oct 09, 2019 |
| Close Date: |
Nov 08, 2019 |
| Last Updated Date: |
Oct 09, 2019 |
| Award Ceiling: |
$41,822,342 |
| Award Floor: |
$0 |
| Estimated Total Program Funding: |
|
| Expected Number of Awards: |
1 |
| Description: |
The goal of this Cooperative Agreement is to engage in a collaborative research and development (R&D) effort to support the research mission of NAMRU-6. The collaborative R&D effort will include conducting clinical trials, and epidemiologic studies in support of clinical trials, so products can be approved/cleared by the U.S. Food and Drug Administration (FDA) for use by the warfighter. |
| Version: |
1 |
